domperidone has been researched along with Stroke in 2 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The domperidone group experienced significantly less dysphagia, nausea and vomiting, and aspiration pneumonia (P < 0." | 9.51 | Evaluation of domperidone efficacy to prevent aspiration pneumonia in patients with acute ischemic stroke: a randomized clinical trial. ( Allami, A; Kianimajd, S; Mavandadi, S; Paybast, S, 2022) |
| "Etiology identification of the stroke included cardiogenic pathology and coagulopathy, but acitretin treatment was considered the likeliest explanation." | 7.71 | Acitretin-associated thrombotic stroke. ( Davani, S; Kantelip, JP; Muret, P; Royer, B; Ziegler, F, 2002) |
| " The domperidone group experienced significantly less dysphagia, nausea and vomiting, and aspiration pneumonia (P < 0." | 5.51 | Evaluation of domperidone efficacy to prevent aspiration pneumonia in patients with acute ischemic stroke: a randomized clinical trial. ( Allami, A; Kianimajd, S; Mavandadi, S; Paybast, S, 2022) |
| "Etiology identification of the stroke included cardiogenic pathology and coagulopathy, but acitretin treatment was considered the likeliest explanation." | 3.71 | Acitretin-associated thrombotic stroke. ( Davani, S; Kantelip, JP; Muret, P; Royer, B; Ziegler, F, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allami, A | 1 |
| Kianimajd, S | 1 |
| Mavandadi, S | 1 |
| Paybast, S | 1 |
| Royer, B | 1 |
| Ziegler, F | 1 |
| Muret, P | 1 |
| Davani, S | 1 |
| Kantelip, JP | 1 |
1 trial available for domperidone and Stroke
| Article | Year |
|---|---|
Evaluation of domperidone efficacy to prevent aspiration pneumonia in patients with acute ischemic stroke: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Domperidone; Female; Humans; Ischemic Stroke; Male; Middle Aged; Pneumonia; | 2022 |
1 other study available for domperidone and Stroke
| Article | Year |
|---|---|
Acitretin-associated thrombotic stroke.
Topics: Acitretin; Analgesics; Anticoagulants; Antiemetics; Dextropropoxyphene; Domperidone; Female; Headach | 2002 |